StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Earnings

Assembly Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 18, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$3.00M
-72.2% on a year earlier
EPS, Q3 FY2026
-$0.93
-$0.72 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Assembly Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 18, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$3.00M-72.2%-$0.93Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026during market hours$13.40M+39.6%–Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours$8.20M-12.8%-$0.54Release
Q4 FY2025ended Dec 31, 2025Mar 19, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025during market hours$10.80M+58.8%-$0.72Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$9.60M+12.9%-$1.33Release
Q1 FY2025ended Mar 31, 2025May 8, 2025during market hours$9.40M+62.1%-$1.17Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024during market hours$6.80M–-$1.51Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024during market hours$8.50M–-$1.98Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours$5.80M–-$1.66Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Assembly Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Assembly Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Assembly Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. News
  5. Update
  6. Results
  7. Results
  8. Update
  9. Results
  10. News
  11. Update
  12. Results
  13. Results
  14. News
  15. Results

See a number that looks wrong?